Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cerebellum-based Imaging Neural Markers for Antipsychotic Response
Sponsor: Northwell Health
Summary
This study will investigate neural markers in the cerebellar-cortical circuitry that predict treatment response to antipsychotics in first-episode psychosis. A total of 120 patients diagnosed with a first-episode psychotic disorder will be recruited. All subjects receive naturalistic treatment with either risperidone or aripiprazole for 12 weeks, with dosage and titration followed by standard clinical care. A comprehensive clinical and neuroimaging assessments will be performed before and after treatment.
Official title: Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis
Key Details
Gender
All
Age Range
16 Years - 40 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2025-11-01
Completion Date
2030-06-01
Last Updated
2026-04-06
Healthy Volunteers
No
Conditions
Interventions
Risperidone
Naturalistic treatment
Locations (1)
Zucker Hillside Hospital
Glen Oaks, New York, United States